If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
8.50    0.00 (0.00%)
Bid:
8.00
Ask:
9.00
Spread: 1.00 (12.50%)
Market Cap: £3.80m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update

Today 07:00

RNS Number : 6014L
Jarvis Securities plc
09 July 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, for a total consideration of up to £11m to Interactive Investor Services Limited (the "Transaction"). The £9m initial consideration was paid to JIML straight away with the remaining £2 million of the consideration deferred for up to c.18 months and subject to potential adjustment for claims under the sale agreement ("Deferred Consideration"), 

The Company is pleased to announce that JIML has now received the first Deferred Consideration payment of £1m plus accrued interest, for a total payment of c.£1,029,000. The second and final Deferred Consideration payment, also of £1m (subject to potential adjustment for claims under the sale agreement) is due on or around 7 January 2027.

At this stage it is intended that JIML will retain these funds during the wind down process after which any surplus will be available for the benefit of the Company, if JIML has not been sold pursuant to the potential sale process announced on 5 May 2026. At this stage there can be no certainty as to the timing of any sale of JIML or that it will occur at all. Full details of the proposed disposal are set out in the Company's announcement of 5 May 2026.

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis Securities plc

 01892 510 515

Andrew Grant

Zeus Capital (Nominated Adviser)

020 3829 5000 

Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSSWFAAEMSEDW
Date   Source Headline
23rd Jul 20157:00 amRNSInterim Results
16th Jun 20157:00 amRNSDividend Declaration
9th Jun 201511:04 amRNSTR-1: Notification of Major Interest in Shares
3rd Jun 20157:00 amRNSTransaction in Own Shares
29th May 201510:01 amRNSDirector's Dealing - Correction
29th May 20157:00 amRNSDirector's Dealings
28th May 20159:14 amRNSTransaction in Own Shares
13th May 20157:00 amRNSDividend Declaration
12th May 20157:01 amRNSExercise of Options & Director's Interest
11th May 20157:00 amRNSDirector/PDMR Shareholding
28th Apr 20159:09 amRNSDirector/PDMR Shareholding
27th Apr 20151:43 pmRNSDirector/PDMR Shareholding
23rd Apr 20155:20 pmRNSDirector/PDMR Shareholding
16th Apr 201510:24 amRNSTransaction in Own Shares - Correction
16th Apr 20157:00 amRNSTransaction in Own Shares
13th Apr 20152:33 pmRNSExercise of Options
26th Mar 20153:58 pmRNSResult of AGM
25th Mar 20157:00 amRNSDirector/PDMR Shareholding
20th Mar 20152:46 pmRNSDirector/PDMR Shareholding
18th Mar 20154:06 pmRNSTransaction in Own Shares
16th Mar 201512:00 pmRNSDirector/PDMR Shareholding
11th Mar 20159:25 amRNSTransaction in Own Shares
5th Mar 20151:52 pmRNSDirector/PDMR Shareholding
19th Feb 20157:00 amRNSFinal Results
11th Feb 20157:00 amRNSDividend Declaration
5th Nov 20147:00 amRNSDividend Declaration
31st Jul 20147:00 amRNSDirector's Interest
24th Jul 20147:00 amRNSInterim Results and Dividend Declaration
27th Jun 20147:00 amRNSExercise of Options
2nd Jun 201411:01 amRNSExercise of Options
20th May 20147:00 amRNSExercise of Options
14th May 201412:26 pmRNSDividend Declaration
8th May 20147:00 amRNSExercise of Options & Director's Interest
11th Apr 201412:28 pmRNSExercise of Options & Director's Interest
27th Mar 201411:09 amRNSResults of AGM and Exercise of Options
24th Feb 20147:48 amRNSExercise of Options and Director's Interest
20th Feb 20147:00 amRNSFinal Results
13th Feb 20147:00 amRNSDividend Declaration
5th Feb 201412:28 pmRNSExercise of Options
28th Nov 201311:59 amRNSReplacement: Exercise of Options
27th Nov 20135:31 pmRNSExercise of Options
12th Nov 20137:01 amRNSDividend Declaration
28th Oct 20132:16 pmRNSIssue of Equity
9th Oct 20137:00 amRNSExercise of Options
12th Sep 20137:00 amRNSExercise of Options
10th Sep 20137:00 amRNSExercise of Options
27th Aug 20134:08 pmRNSTR1 - Notification of major interest in shares
15th Aug 20134:05 pmRNSTR1 - Notification of major interest in shares
15th Aug 20134:00 pmRNSDirector's Interest
12th Aug 20137:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.